Stockreport

Vaccinex, Inc. Announces Reverse Stock Split

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treat [Read more]